All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, August 17, 2022
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Free access to BioWorld coronavirus articles

Aug. 16, 2022
No Comments
The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note that we have added three critical tables, which are continuously updated:

Vaccines and therapeutics in development
Diagnostics with U.S. FDA emergency use authorization
Clinical trials of biopharma products affected by COVID-19
Read More

Other news to note for Aug. 16, 2022

Aug. 16, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Addex, Alzecure, Artelo, Contrafect, Daiichi, Epiaxis, Epizyme, Hifibio, Horizon, Immunis, Ipsen, Novartis, Peptilogics, Pharmacyte, Q32, Seagen, Zyversa.
Read More
Moderna vaccine vial and syringe on tray

Moderna clocks up UK approval for first bivalent COVID-19 mRNA vaccine

Aug. 15, 2022
By Cormac Sheridan
No Comments
Moderna Inc. has received conditional authorization from the U.K.’s Medicines and Healthcare Products Regulatory Agency for its bivalent COVID-19 booster vaccine mRNA-1273.214 (Spikevax bivalent original/omicron). The conditional approval, which covers adults aged 18 years and older, marks a new phase in the ongoing global effort to curb the COVID-19 pandemic, as the new vaccine represents the first commercial product to incorporate omicron-specific epitopes. It contains 25 micrograms each of the spike proteins of the omicron BA.1 variant and the original Wuhan strain of SARS-CoV-2.
Read More

Regulatory actions for Aug. 15, 2022

Aug. 15, 2022
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acer, Advanced Acclerator Applications, Astrazeneca, Brainstorm, Cullgen, Daewoong, Daiichi, Genentech, Innocare, Larimar, Menarini, Moderna, Novavax, Novelmed, Privo, Relief, Small, Spectrum, Stemline.
Read More

In the clinic for Aug. 15, 2022

Aug. 15, 2022
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alx, Astrazeneca, Blueprint, Clene, Gilead, Immunogenx, Novartis, Passage, Plus, Roche, Sanofi, Viridian and Virios.
Read More

Other news to note for Aug. 12, 2022

Aug. 12, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Ceapro, Fortress, Ginkgo, Homology, Nanopharmaceutics, Pasithea, Synlogic, Teneotwo.
Read More

Other news to note for Aug. 11, 2022

Aug. 11, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpine Immune, Intron, Evotec, Proqr, Psilera, SAB, Starpharma, Tetra, Vir, Volitionrx, Zai Lab.
Read More

In the clinic for Aug. 10, 2022

Aug. 10, 2022
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alphamab, Amgen, Asieris, Beigene, Frontier, Hutchmed, Inmagene, Kintor, Pfizer, Photocure, Saol, Vaccinex, Valneva, Verona, Xilio.
Read More

Regulatory actions for Aug. 9, 2022

Aug. 9, 2022
No Comments
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avenda, Bodyport, Bot Image, Cerevasc, Imspex Diagnostics, Medalliance, Neuroone.
Read More
Respiratory infection

Taiwan’s Syneurx gears up for phase III test of COVID-19 oral antiviral

Aug. 9, 2022
By Tamra Sami
No Comments
Following the readout of a phase II trial evaluating its COVID-19 oral antiviral Pentarlandir (SNB-01), Taiwan’s Syneurx International Corp. said it expects to launch a phase III test of the candidate in the next few months.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 463 464 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 16, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Aug. 16, 2022.
  • Pig organ cells

    Whole body cellular function recovery in pigs after death

    Science
    A new system for restoring cell function and tissues in mammals after death could expand the availability of organs for transplantation. The research also opens...
  • TPOXX

    Siga leads monkeypox antiviral research, amid lack of interest from big pharma

    BioWorld
    After declarations from the World Health Organization and the U.S. government that monkeypox is a public health emergency, attention is turning to the pharma...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing